Peer education

Find Your AbbVie MSL

Upload date: 04/21/2021

A tool for healthcare professionals to find a local AbbVie Medical Science Liason

An animation highlighting how patients with HCV and treatments have changed, emphasizing the role that non-HCV specialists can play in treating Hepatitis C

NASTAD Community Navigation Model and Toolkit

Upload date: 04/21/2021

A toolkit consisting of program protocols, data collection tools and patient education materials to support community health organizations to …

A toolkit consisting of program protocols, data collection tools and patient education materials to support community health organizations to navigate patients through complete diagnostic testing, linkage to care or return to care, treatment, and reinfection prevention after cure

Anatomy of the liver

Upload date: 04/21/2021 | Time to read: 1:16

Animation on the structure and function of the liver

View Link

An animation highlighting how patients with HCV and treatments have changed, emphasizing the role that non-HCV specialists can play in treating Hepatitis C

Fibrosis and cirrhosis of the liver

Upload date: 04/21/2021 | Time to read: 3:13

A summary of the causes of fibrosis, how it occurs, the different stages and what cirrhosis is

View Link

An animation highlighting how patients with HCV and treatments have changed, emphasizing the role that non-HCV specialists can play in treating Hepatitis C

Identifying and managing patients without cirrhosis

Upload date: 04/21/2021 | Time to read: 2:46

An animation explaining who patients without cirrhosis are, how to measure if a patient is non-cirrhotic and AASLD-IDSA guidelines on how to …

View Link

An animation explaining who patients without cirrhosis are, how to measure if a patient is non-cirrhotic and AASLD-IDSA guidelines on how to manage them

Identifying and managing patients with cirrhosis - compensated vs. decompensated liver disease

Upload date: 04/21/2021 | Time to read: 2:52

An animation to highlight the differences between compensated and decompensated cirrhosis, how to measure the severity of cirrhosis AASLD-IDSA …

View Link

An animation to highlight the differences between compensated and decompensated cirrhosis, how to measure the severity of cirrhosis AASLD-IDSA guidelines on how to manage them

Assessing liver damage cuased by HCV infection: common laboratory tets

Upload date: 04/21/2021 | Time to read: 6:30

An overview of the different laboratory tests that are recommended prior to treating patients with HCV infection and what the test results could indicate

View Link

An animation highlighting how patients with HCV and treatments have changed, emphasizing the role that non-HCV specialists can play in treating Hepatitis C

How can liver damage be assessed to identify patients for simplified HCV treatment

Upload date: 04/21/2021 | Time to read: 4:55

An animation explaining the different methods that can be used to assess fibrosis and cirrhosis to help identify patients who are eligible for simplified treatment

View Link

An animation highlighting how patients with HCV and treatments have changed, emphasizing the role that non-HCV specialists can play in treating Hepatitis C

Transcript

Telemedicine: The "New Normal" for Managing Hepatitis C care

Upload date: 04/21/2021 | Time to read: 30:21

A webinar with Dr Tipu Khan covering the impact of COVID-19 on HCV screening, diagnosis and care, and the role of telemedicine in managing HCV patients

Watch Video

Background information on the changing epidemiolgy of HCV in recent years with a particular focus on the increasing prevalence of PWID who are presenting with infection. This also includes details on barriers to care among PWID and the importance of simplifying the treatment cascade